Phibro Animal Health Co. (NASDAQ:PAHC) to Issue Quarterly Dividend of $0.12

Phibro Animal Health Co. (NASDAQ:PAHC - Get Free Report) announced a quarterly dividend on Tuesday, November 5th,Zacks Dividends reports. Shareholders of record on Wednesday, November 27th will be paid a dividend of 0.12 per share on Wednesday, December 18th. This represents a $0.48 annualized dividend and a yield of 2.04%. The ex-dividend date of this dividend is Wednesday, November 27th.

Phibro Animal Health has a dividend payout ratio of 32.7% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Phibro Animal Health to earn $1.91 per share next year, which means the company should continue to be able to cover its $0.48 annual dividend with an expected future payout ratio of 25.1%.

Phibro Animal Health Trading Up 1.8 %

Shares of Phibro Animal Health stock traded up $0.41 on Thursday, hitting $23.50. 287,585 shares of the company traded hands, compared to its average volume of 155,331. The stock's 50 day moving average price is $22.28 and its 200-day moving average price is $19.24. The company has a current ratio of 2.94, a quick ratio of 1.64 and a debt-to-equity ratio of 1.79. Phibro Animal Health has a 52 week low of $9.40 and a 52 week high of $25.11. The company has a market cap of $951.75 million, a PE ratio of 389.40, a PEG ratio of 0.55 and a beta of 0.51.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its quarterly earnings results on Wednesday, August 28th. The company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.34 by $0.07. The firm had revenue of $273.16 million during the quarter, compared to the consensus estimate of $262.44 million. Phibro Animal Health had a net margin of 0.24% and a return on equity of 18.08%. Equities research analysts predict that Phibro Animal Health will post 1.57 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on the stock. JPMorgan Chase & Co. assumed coverage on shares of Phibro Animal Health in a report on Tuesday, September 10th. They issued a "neutral" rating and a $22.00 price target on the stock. Bank of America lifted their price target on shares of Phibro Animal Health from $13.00 to $15.00 and gave the stock an "underperform" rating in a report on Friday, August 30th. Three investment analysts have rated the stock with a sell rating, two have assigned a hold rating and one has issued a buy rating to the company's stock. According to data from MarketBeat, Phibro Animal Health has a consensus rating of "Hold" and an average price target of $15.00.

Insider Activity

In related news, Director E Thomas Corcoran acquired 5,000 shares of the company's stock in a transaction dated Wednesday, September 4th. The shares were purchased at an average cost of $20.02 per share, with a total value of $100,100.00. Following the completion of the acquisition, the director now directly owns 25,000 shares of the company's stock, valued at $500,500. This represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 50.07% of the company's stock.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.